AzTrials
AzTrials

Bell PalsyNCT06028191

Combined Effects of Low Level Laser Therapy and Kabat Technique in Patients With Bell's Palsy

A study testing Kabat Technique along with baseline treatment and Kabat Technique and LLLT along with baseline treatment in people with Bell Palsy, run by Riphah International University at 2 sites in Pakistan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of this current study is to determine the combined effects of Low-Level Laser Therapy (LLLT) and the Kabat technique on quality of life, synkinetic movements and functional outcome in patients of Bell's palsy Read more about this study

Who is it for?
Ages 18 to 40 years
Conditions the study is for
Bell Palsy
What is being tested?
Kabat Technique along with baseline treatment and Kabat Technique and LLLT along with baseline treatment
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
2 sitesPakistan
Study dates
17 Jul 2023to Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-40
  • Both genders will be included
  • Unilateral Facial paralysis/paresis
  • Patients presented within onset of 12 days - 3 weeks (sub-acute Bell's Palsy)

Who cannot join

  • Previous surgery of facial reconstruction
  • Traumatic Brain Injury
  • Any other neurological deficit
  • Congenital Deformities
  • Recurrent Bell's palsy will be excluded

Trial locations and contacts

2 sites in 1 country.

Fatima Tariq, Mphil contact

03344255033

fatima.tariq@riphah.edu.pk

Pakistan2 sites, 2 recruiting
  • Allied Hospital

    Faisalābad, Punjab Province, 38000

    Fatima Tariq, Mphil, 03344255033, fatima.tariq@riphah.edu.pk

    Recruiting
  • Physiofit

    Faisalābad, Punjab Province, 38000

    Fatima Tariq, Mphi;, 03344255033, fatima.tariq@riphah.edu.pk

    Recruiting

Other trials in Pakistan

About this study

The objective of this current study is to determine the combined effects of Low-Level Laser Therapy (LLLT) and the Kabat technique on quality of life, synkinetic movements and functional outcome in patients of Bell's palsy

Read the detailed description

Bell's palsy is an acute condition which occurs by the damage of 7th cranial nerve along its course at the level which is distal to Pons. Basically it is an idiopathic facial condition.

The yearly incidence of Bell's palsy is 15 to 30 per 100,000 people, which affect both sexes equally. This study aims to see combined effects of Low Level Laser Therapy and Kabat technique in the treatment of Bell's palsy.

Synkinesis, which is described as an involuntary movement in one part of the face produced during voluntary movement in another region of the face, is a problematic Bell's palsy sequel. The mechanism behind the formation of synkinesis is unknown. According to the predominant idea, damaged axons regenerate abnormally, innervating facial muscles that weren't originally innervated. The yearly incidence of Bell's palsy is 15 to 30 per 100,000 people, which affect both sexes equally.

Kabat Technique is neurorehabilitation technique that uses diagonal and spiral patterns for movement in conjunction with stretch and resistance and other PNF techniques to reinforce neuromuscular recruitment. It mainly concerns the stimulation of these muscles: Orbicularis occuli, ztgomaticus, Levator labii, nasalis, buccinator, frontalis, corrugator.

For all BP patients, including those who are unable to take corticosteroids due to diabetes or hypertension, laser therapy offers a non-invasive, painless means of treatment. However, just a few researches have examined the effectiveness of low- dose laser therapy in BP patients.

Low Level Laser Therapy has the potential to promote nerve regeneration, reduce inflammation, and accelerate tissue healing in the affected facial nerve. On the other hand, the Kabat technique focuses on restoring neuromuscular control and improving muscle function. By combining Low Level Laser Therapy and the Kabat technique, a synergistic effect may be achieved, maximizing the potential benefits of both interventions. Therefore, this study aims to determine the specific parameters and protocols for the combined use of Low Level Laser Therapy and the Kabat technique in Bell's palsy

Conditions
Bell Palsy
Being tested
Kabat Technique along with baseline treatment, Kabat Technique and LLLT along with baseline treatment
Keywords
Bell's Palsy, Facial Disability Index, Kabat Technique, Low Level Laser Therapy, Sunnybrook facial grading system
Medical subject headings
Bell Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Kabat Technique along with baseline treatmentOther

    Also called Group A

    Group A will receive Kabat Technique along with baseline treatment. Electrical muscle stimulation for 15 min which includes faradic current to the facial nerve trunks given by DL-2 electro pulse stimulator, Effleurage and Kneading for 5 min and resistive exercise for 5 min and facial expression exercises for 5 min, which included eye closure, eyebrow raise, frown, smile, snarl, pucker and pout as baseline treatment.

    Kabat Technique is neurorehabilitation technique that uses diagonal and spiralpatterns for movement in conjunction with stretch and resistance and other PNF techniques to reinforce neuromuscular recruitment. It mainly concerns the stimulation of these muscles: Orbicularis occuli, ztgomaticus, Levator labii, nasalis, buccinator, frontalis, corrugator

  • Kabat Technique and LLLT along with baseline treatmentDevice

    Also called Group B

    Group B will receive Kabat Technique and LLLT along with baselinetreatment. Kabat technique is same as mentioned in group A. Laser treatment will be administered to eight points of the affected side for 2 min at each point at a wavelength of 830 nm, output power of 100 Mw, and frequency of 1 KHz. Endo laser 422 is the model name and number of device which will be used in this study to administered low level laser therapy.

Study groups in NCT06028191
Study groupRoleWhat they receive
Kabat Technique along with baseline treatmentOtherKabat technique will be performed for 15 min along with baseline treatment will be given to Group A. They will have 45 min-1 hour session thrice a week in duration of six weeks.
Receives: Other: Kabat Technique along with baseline treatment
Kabat Technique and LLLT along with baseline treatmentExperimentalKabat technique will be performed for 15 min and LLLT will be performed for 10 min to eight points of the effected side for 2 min at each point along with baseline treatment. They will have 45 min-1 hour session thrice a week in duration of six weeks
Receives: Device: Kabat Technique and LLLT along with baseline treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sunnybrook Facial Grading system

    Sunnybrook facial grading system was used to quantify the symmetry of voluntary and resting muscles

    Measured: 6 weeks

Secondary outcomes (1)
  1. Facial disability index

    it has two components. The physical function subscale detects problems in drinking, speaking eating, lacrimation, and oral hygiene. The social/well-being function subscale detects subjective irritation, perception of anxiety, and isolation; problems in sleeping; and limitations in social participation.

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2023
  2. Study start17 Jul 2023
  3. Primary completionOct 2023 (estimated)
  4. Study completionDec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06028191
Sponsor's protocol ID
REC/RCR & AHS/23/0229
Status last verified
Aug 2023
First submitted
31 Aug 2023
Last updated
8 Sep 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Kabat Technique along with baseline treatment and Kabat Technique and LLLT along with baseline treatment in people with Bell Palsy, run by Riphah International University at 2 sites in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Fatima Tariq, Mphil (03344255033, fatima.tariq@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sunnybrook Facial Grading system (time frame: 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2023; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in